Robert F. Kennedy Jr. is amassing Americans' private medical records for a new autism study. Data will be collected from ...

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

Facing federal funding uncertainty, a looming workforce shortage and an increasingly aging patient population, cancer center leaders in the U.S. remain undeterred. Their focus remains, as it has for ...

Inhibition of GSK-3β may inhibit tumor growth and improve survival through several complimentary mechanisms that include enhancement of chemotherapy activity, activation of innate anti-tumor immunity, ...

Antiretroviral therapy has revolutionized treatment for persons living with HIV, transforming what was once a death sentence ...

Chronic pain often leads practitioners to prescribe opioids, though prescribed opioids have created a nationwide crisis that ...

MetroHealth is the latest health care system to implement AI technology to help clinical workflows become more time-efficient ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are designed to lower high blood glucose levels ...

Because I was treated at a major academic center ... newly diagnosed patient today, I think often about what terrified the 18-year-old version of myself. I think about the clinical trial that ...

Doctors and public health specialists say they view the administration's actions, such as firings or questioning established research, as an "attack" on science.

An NIH initiative led by Secretary Robert F. Kennedy Jr. aims to amass extensive private medical records for autism research, sparking privacy concerns. This follows Kennedy's controversial statements ...